PA452 luvastatin High-Affinity RGD-Knottin Peptide as a

High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to αvβ3

InChi: InChI=1S/C137H230N48O39/c1-10-72(8)107(129(221)177-91(131(223)224)42-48-100(143)190)183-127(219)97-35-24-60-185(97)130(222)96(63-71(6)7)182-125(217)94(65-74-25-12-11-13-26-74)180-118(210)86(43-49-103(193)194)165-102(192)68-163-128(220)108(73(9)186)184-122(214)90(45-51-105(197)198)174-120(212)89(44-50-104(195)196)176-126(218)95(66-106(199)200)181-124(216)93(62-70(4)5)179-121(213)88(41-47-99(142)189)175-123(215)92(61-69(2)3)178-117(209)85(34-23-59-161-137(154)155)171-114(206)82(31-20-56-158-134(148)149)169-115(207)83(32-21-57-159-135(150)151)172-119(211)87(40-46-98(141)188)173-116(208)84(33-22-58-160-136(152)153)170-113(205)81(30-19-55-157-133(146)147)168-112(204)80(28-15-17-53-139)167-111(203)79(27-14-16-52-138)166-110(202)78(29-18-54-156-132(144)145)164-101(191)67-162-109(201)77(140)64-75-36-38-76(187)39-37-75/h11-13

10-trioxo-1H

female BALB/c nude mice) treatment enhances cisplatin efficacy in PDX models

9(15):5749-55

PA452 luvastatin High-Affinity RGD-Knottin Peptide as aPA452, retinoic X receptor (RXR) specific antagonist, inhibits the effect of Retinoic acid (RA) on Th1 Th2 development. Product information CAS Number: 457657 34 0 Molecular Weight: 439. 59 Formula: C26H37N3O3 Chemical Name: 2 {[3 (hexyloxy) 5,5,8,8 tetramethyl 5,6,7,8 tetrahydronaphthalen 2 yl](methyl)amino}pyrimidine 5 carboxylic acid Smiles: CCCCCCOC1=CC2=C(C=C1N(C)C1N=CC(=CN=1)C(O)=O)C(C)(C)CCC2(C)C InChiKey: JJUUTJCZMGZJDZ UHFFFAOYSA N InChi: